Demographic analysis and outcome features in a transplant outpatient clinic.
OBJECTIVE
This retrospective report analyzed the demographic features of kidney transplant outpatients grafted in Turkey and in different regions of the world.


METHODS
The patients were divided into 4 groups: Every cohort was subgrouped as either receiving a cadaveric (CT) or a live donor transplant (LT) performed in our institute (ICT, n = 147, ILT, n = 304), other institutions in Turkey (TCT, n = 16, TLT, n = 86), or in a foreign country (FCT, n = 66, FLT, n = 154).


RESULTS
Among the patients with functional grafts, FLT transplantations, of which the vast majority were paid transplantations, constituted the second largest group (n = 105) following ILT (n = 214). In the ILT group, 5- and 10-year graft survival rates were 76% and 50%, respectively, and patient survival rates were 88% and 78%, respectively. Considering the FLT group, 5- and 10-year graft survival figures were 70% and 42%, respectively, while patient survival rates in these periods were 81% and 69%, respectively. Patients with paid donor transplantations were characterized by a high risk of unconventional infectious complications in the early period, while midterm patient and graft survival was somewhat better than expected considering the high rate of complications in the early period.


CONCLUSIONS
Paid organ transplantation should be discouraged. Organ donation should be stimulated by every means to avoid potentially fatal unconventional infections after transplantation from paid donors. If patients receive a paid transplant, however, they should be closely followed for these complications, since, if they survive the early period the midterm and long-term outcomes are quite reasonable.
Kucuk
M
M
SSK Okmeydani Hospital, Istanbul, Turkey. leylak73@yahoo.com
Sever
M S
MS
Turkmen
A
A
Sahin
S
S
Kazancioglu
R
R
Ozturk
S
S
Eldegez
U
U
D000328:Adult; D002102:Cadaver; D015331:Cohort Studies; D003710:Demography; D005260:Female; D005843:Geography; D006801:Humans; D016030:Kidney Transplantation / Q000191:economics / Q000401:mortality / Q000502:physiology*; D019520:Living Donors; D008297:Male; D016019:Survival Analysis; D014019:Tissue Donors; D016896:Treatment Outcome; D014421:Turkey